205 related articles for article (PubMed ID: 7758129)
61. Mast cell growth-enhancing activity (MEA) stimulates interleukin 6 production in a mouse bone marrow-derived mast cell line and a malignant subline.
Hültner L; Moeller J
Exp Hematol; 1990 Sep; 18(8):873-7. PubMed ID: 2117548
[TBL] [Abstract][Full Text] [Related]
62. Induction of interferon-gamma production and Ia expression by interleukin 1 in bone marrow culture cells.
Puri J; Eglash B; Lonai P
Eur J Immunol; 1987 Feb; 17(2):223-8. PubMed ID: 3104062
[TBL] [Abstract][Full Text] [Related]
63. Regulation of antigen-presentation-I. IFN-gamma induces antigen-presenting properties on B cells.
Hawrylowicz CM; Unanue ER
J Immunol; 1988 Dec; 141(12):4083-8. PubMed ID: 2974053
[TBL] [Abstract][Full Text] [Related]
64. The capacity of bone marrow-derived macrophages to process bovine insulin is regulated by lymphokines.
Frosch S; Bonifas U; Reske-Kunz AB
Int Immunol; 1993 Dec; 5(12):1551-8. PubMed ID: 8312225
[TBL] [Abstract][Full Text] [Related]
65. Rat peritoneal mast cells produce IFN-gamma following IL-12 treatment but not in response to IgE-mediated activation.
Gupta AA; Leal-Berumen I; Croitoru K; Marshall JS
J Immunol; 1996 Sep; 157(5):2123-8. PubMed ID: 8757336
[TBL] [Abstract][Full Text] [Related]
66. IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway.
Frandji P; Mourad W; Tkaczyk C; Singer M; David B; Colle JH; Mécheri S
Eur J Immunol; 1998 Mar; 28(3):844-54. PubMed ID: 9541579
[TBL] [Abstract][Full Text] [Related]
67. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells.
Frei K; Siepl C; Groscurth P; Bodmer S; Schwerdel C; Fontana A
Eur J Immunol; 1987 Sep; 17(9):1271-8. PubMed ID: 3115791
[TBL] [Abstract][Full Text] [Related]
68. Different cytokines regulate antigen uptake and presentation of a precursor dendritic cell line.
Lutz MB; Assmann CU; Girolomoni G; Ricciardi-Castagnoli P
Eur J Immunol; 1996 Mar; 26(3):586-94. PubMed ID: 8605925
[TBL] [Abstract][Full Text] [Related]
69. IL-3 in dendritic cell development and function: a comparison with GM-CSF and IL-4.
Lutz MB
Immunobiology; 2004; 209(1-2):79-87. PubMed ID: 15481143
[TBL] [Abstract][Full Text] [Related]
70. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor.
Hornell TM; Beresford GW; Bushey A; Boss JM; Mellins ED
J Immunol; 2003 Sep; 171(5):2374-83. PubMed ID: 12928384
[TBL] [Abstract][Full Text] [Related]
71. Rat connective tissue-type mast cells express MHC class II: up-regulation by IFN-gamma.
Warbrick EV; Taylor AM; Botchkarev VA; Coleman JW
Cell Immunol; 1995 Jul; 163(2):222-8. PubMed ID: 7606795
[TBL] [Abstract][Full Text] [Related]
72. Granulocyte-macrophage colony stimulating factor inhibits class II major histocompatibility complex expression and antigen presentation by microglia.
Hayashi M; Dorf ME; Abromson-Leeman S
J Neuroimmunol; 1993 Oct; 48(1):23-32. PubMed ID: 7901233
[TBL] [Abstract][Full Text] [Related]
73. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.
Ihle JN; Keller J; Oroszlan S; Henderson LE; Copeland TD; Fitch F; Prystowsky MB; Goldwasser E; Schrader JW; Palaszynski E; Dy M; Lebel B
J Immunol; 1983 Jul; 131(1):282-7. PubMed ID: 6190911
[TBL] [Abstract][Full Text] [Related]
74. Induction of MHC class II antigen expression on murine microglia by interleukin-3.
Imamura K; Suzumura A; Sawada M; Mabuchi C; Marunouchi T
J Neuroimmunol; 1994 Dec; 55(2):119-25. PubMed ID: 7829662
[TBL] [Abstract][Full Text] [Related]
75. Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism.
Gomi K; Zhu FG; Marshall JS
J Immunol; 2000 Dec; 165(11):6545-52. PubMed ID: 11086097
[TBL] [Abstract][Full Text] [Related]
76. Functional heterogeneity of culture-grown bone marrow-derived macrophages. II. Lymphokine stimulation of antigen-presenting function.
Lee KC; Wong M
J Immunol; 1982 Jun; 128(6):2487-92. PubMed ID: 6978905
[TBL] [Abstract][Full Text] [Related]
77. Synergism of glucocorticoids with granulocyte macrophage colony stimulating factor (GM-CSF) but not interferon gamma (IFN-gamma) or interleukin-4 (IL-4) on induction of HLA class II expression on human monocytes.
Sadeghi R; Hawrylowicz CM; Chernajovsky Y; Feldmann M
Cytokine; 1992 Jul; 4(4):287-97. PubMed ID: 1515553
[TBL] [Abstract][Full Text] [Related]
78. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells.
Aloisi F; De Simone R; Columba-Cabezas S; Penna G; Adorini L
J Immunol; 2000 Feb; 164(4):1705-12. PubMed ID: 10657614
[TBL] [Abstract][Full Text] [Related]
79. Long-term in vitro culture of murine mast cells. III. Discrimination of mast cells growth factor and granulocyte-CSF.
Yung YP; Moore MA
J Immunol; 1982 Sep; 129(3):1256-61. PubMed ID: 6809816
[TBL] [Abstract][Full Text] [Related]
80. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
Sallusto F; Lanzavecchia A
J Exp Med; 1994 Apr; 179(4):1109-18. PubMed ID: 8145033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
